Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2024

Open Access 01-12-2024 | Colorectal Cancer | Research

Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation

Authors: Fuchao Li, Lei Liu, Qingzhao Feng, Xiaohong Wang, Fang Liu, Li Yang, Lin Miao, Weiming Wang, Guozhong Ji, Chenggong Yu

Published in: World Journal of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Background

Colorectal signet-ring cell carcinoma (SRCC) is a rare cancer with a bleak prognosis. The relationship between its clinicopathological features and survival remains incompletely elucidated. Tumor deposits (TD) have been utilized to guide the N staging in the 8th edition of American Joint Committee on Cancer (AJCC) staging manual, but their prognostic significance remains to be established in colorectal SRCC.

Patients and methods

The subjects of this study were patients with stage III/IV colorectal SRCC who underwent surgical treatment. The research comprised two cohorts: a training cohort and a validation cohort. The training cohort consisted of 631 qualified patients from the SEER database, while the validation cohort included 135 eligible patients from four independent hospitals in China. The study assessed the impact of TD on Cancer-Specific Survival (CSS) and Overall Survival (OS) using Kaplan-Meier survival curves and Cox regression models. Additionally, a prognostic nomogram model was constructed for further evaluation.

Results

In both cohorts, TD-positive patients were typically in the stage IV and exhibited the presence of perineural invasion (PNI) (P < 0.05). Compared to the TD-negative group, the TD-positive group showed significantly poorer CSS (the training cohort: HR, 1.87; 95% CI, 1.52–2.31; the validation cohort: HR, 2.43; 95% CI, 1.55–3.81; all P values < 0.001). This association was significant in stage III but not in stage IV. In the multivariate model, after adjusting for covariates, TD maintained an independent prognostic value (P < 0.05). A nomogram model including TD, N stage, T stage, TNM stage, CEA, and chemotherapy was constructed. Through internal and external validation, the model demonstrated good calibration and accuracy. Further survival curve analysis based on individual scores from the model showed good discrimination.

Conclusion

TD positivity is an independent factor of poor prognosis in colorectal SRCC patients, and it is more effective to predict the prognosis of colorectal SRCC by building a model with TD and other clinically related variables.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119:785–92.CrossRefPubMedPubMedCentral Brenner H, Chen C. The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. Br J Cancer. 2018;119:785–92.CrossRefPubMedPubMedCentral
2.
go back to reference Shi T, Huang M, Han D, et al. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: a Surveillance, Epidemiology, and end results database analysis. Cancer Med. 2019;8:1930–40.CrossRefPubMedPubMedCentral Shi T, Huang M, Han D, et al. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: a Surveillance, Epidemiology, and end results database analysis. Cancer Med. 2019;8:1930–40.CrossRefPubMedPubMedCentral
3.
go back to reference Fadel MG, Malietzis G, Constantinides V, et al. Clinicopathological factors and survival outcomes of signet-ring cell and mucinous carcinoma versus adenocarcinoma of the colon and rectum: a systematic review and meta-analysis. Discov Oncol. 2021;12:5.CrossRefPubMedPubMedCentral Fadel MG, Malietzis G, Constantinides V, et al. Clinicopathological factors and survival outcomes of signet-ring cell and mucinous carcinoma versus adenocarcinoma of the colon and rectum: a systematic review and meta-analysis. Discov Oncol. 2021;12:5.CrossRefPubMedPubMedCentral
4.
go back to reference Benesch MGK, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2020; 12. Benesch MGK, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers (Basel) 2020; 12.
5.
go back to reference Alvi MA, Loughrey MB, Dunne P, et al. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer. 2017;117:203–9.CrossRefPubMedPubMedCentral Alvi MA, Loughrey MB, Dunne P, et al. Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies. Br J Cancer. 2017;117:203–9.CrossRefPubMedPubMedCentral
6.
go back to reference Wang R, Ma X, Li Y, et al. The characteristics and Prognostic Effect of E-Cadherin expression in colorectal Signet Ring Cell Carcinoma. PLoS ONE. 2016;11:e0160527.CrossRefPubMedPubMedCentral Wang R, Ma X, Li Y, et al. The characteristics and Prognostic Effect of E-Cadherin expression in colorectal Signet Ring Cell Carcinoma. PLoS ONE. 2016;11:e0160527.CrossRefPubMedPubMedCentral
7.
go back to reference Nitsche U, Zimmermann A, Spath C, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013;258:775–82. discussion 782 – 773.CrossRefPubMed Nitsche U, Zimmermann A, Spath C, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013;258:775–82. discussion 782 – 773.CrossRefPubMed
8.
go back to reference Wong-Chong N, Motl J, Hwang G, et al. Impact of Tumor deposits on oncologic outcomes in stage III Colon cancer. Dis Colon Rectum. 2018;61:1043–52.CrossRefPubMed Wong-Chong N, Motl J, Hwang G, et al. Impact of Tumor deposits on oncologic outcomes in stage III Colon cancer. Dis Colon Rectum. 2018;61:1043–52.CrossRefPubMed
9.
go back to reference Li J, Yang S, Hu J, et al. Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study. Oncotarget. 2016;7:18269–79.CrossRefPubMedPubMedCentral Li J, Yang S, Hu J, et al. Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study. Oncotarget. 2016;7:18269–79.CrossRefPubMedPubMedCentral
10.
go back to reference Mirkin KA, Kulaylat AS, Hollenbeak CS, Messaris E. Prognostic significance of Tumor deposits in stage III Colon cancer. Ann Surg Oncol. 2018;25:3179–84.CrossRefPubMed Mirkin KA, Kulaylat AS, Hollenbeak CS, Messaris E. Prognostic significance of Tumor deposits in stage III Colon cancer. Ann Surg Oncol. 2018;25:3179–84.CrossRefPubMed
11.
go back to reference Brouwer NPM, Nagtegaal ID. Tumor deposits improve staging in colon cancer: what are the next steps? Ann Oncol. 2021;32:1209–11.CrossRefPubMed Brouwer NPM, Nagtegaal ID. Tumor deposits improve staging in colon cancer: what are the next steps? Ann Oncol. 2021;32:1209–11.CrossRefPubMed
12.
go back to reference Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer. 1988;61:2310–4.CrossRefPubMed Sobin LH, Hermanek P, Hutter RV. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer. 1988;61:2310–4.CrossRefPubMed
13.
go back to reference Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRefPubMed Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRefPubMed
14.
go back to reference Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.CrossRefPubMed Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer staging Manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin. 2017;67:93–9.CrossRefPubMed
15.
go back to reference Cohen R, Shi Q, Meyers J, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)(☆). Ann Oncol. 2021;32:1267–75.CrossRefPubMed Cohen R, Shi Q, Meyers J, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance)(☆). Ann Oncol. 2021;32:1267–75.CrossRefPubMed
16.
go back to reference Konishi T, Shimada Y, Hsu M, et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon cancer outcome. JAMA Oncol. 2018;4:309–15.CrossRefPubMed Konishi T, Shimada Y, Hsu M, et al. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon cancer outcome. JAMA Oncol. 2018;4:309–15.CrossRefPubMed
17.
go back to reference Imperial R, Ahmed Z, Toor OM, et al. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles. Mol Cancer. 2018;17:177.CrossRefPubMedPubMedCentral Imperial R, Ahmed Z, Toor OM, et al. Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles. Mol Cancer. 2018;17:177.CrossRefPubMedPubMedCentral
18.
go back to reference Liang Z, Yan D, Li G, Cheng H. Clinical analysis of primary colorectal Signet-Ring Cell Carcinoma. Clin Colorectal Cancer. 2018;17:e39–44.CrossRefPubMed Liang Z, Yan D, Li G, Cheng H. Clinical analysis of primary colorectal Signet-Ring Cell Carcinoma. Clin Colorectal Cancer. 2018;17:e39–44.CrossRefPubMed
19.
go back to reference Delattre JF, Selcen Oguz Erdogan A, Cohen R, et al. A comprehensive overview of tumour deposits in colorectal cancer: towards a next TNM classification. Cancer Treat Rev. 2022;103:102325.CrossRefPubMed Delattre JF, Selcen Oguz Erdogan A, Cohen R, et al. A comprehensive overview of tumour deposits in colorectal cancer: towards a next TNM classification. Cancer Treat Rev. 2022;103:102325.CrossRefPubMed
20.
go back to reference Ueno H, Nagtegaal ID, Quirke P, et al. Tumor deposits in colorectal cancer: Refining their definition in the TNM system. Ann Gastroenterol Surg. 2023;7:225–35.CrossRefPubMedPubMedCentral Ueno H, Nagtegaal ID, Quirke P, et al. Tumor deposits in colorectal cancer: Refining their definition in the TNM system. Ann Gastroenterol Surg. 2023;7:225–35.CrossRefPubMedPubMedCentral
21.
go back to reference Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N + MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000;88:2228–38.CrossRefPubMed Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N + MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer. 2000;88:2228–38.CrossRefPubMed
22.
go back to reference Wu WX, Zhang DK, Chen SX, et al. Prognostic impact of tumor deposits on overall survival in colorectal cancer: based on Surveillance, Epidemiology, and end results database. World J Gastrointest Oncol. 2022;14:1699–710.CrossRefPubMedPubMedCentral Wu WX, Zhang DK, Chen SX, et al. Prognostic impact of tumor deposits on overall survival in colorectal cancer: based on Surveillance, Epidemiology, and end results database. World J Gastrointest Oncol. 2022;14:1699–710.CrossRefPubMedPubMedCentral
23.
go back to reference Liu C, Tian M, Pei H, et al. Prognostic value of the N1c in Stage III and IV Colorectal Cancer: a propensity score matching study based on the Surveillance, Epidemiology, and end results (SEER) database. J Invest Surg. 2022;35:850–9.CrossRefPubMed Liu C, Tian M, Pei H, et al. Prognostic value of the N1c in Stage III and IV Colorectal Cancer: a propensity score matching study based on the Surveillance, Epidemiology, and end results (SEER) database. J Invest Surg. 2022;35:850–9.CrossRefPubMed
24.
go back to reference Kim JH, Kim H, Kim JW, Kim HM. Trends in the incidence and Survival Rates of Colorectal Signet-Ring Cell Carcinoma in the South Korean Population: analysis of the Korea Central Cancer Registry Database. J Clin Med 2021; 10. Kim JH, Kim H, Kim JW, Kim HM. Trends in the incidence and Survival Rates of Colorectal Signet-Ring Cell Carcinoma in the South Korean Population: analysis of the Korea Central Cancer Registry Database. J Clin Med 2021; 10.
25.
go back to reference Cardoso R, Guo F, Heisser T, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries. Lancet Reg Health Eur. 2022;21:100458.CrossRefPubMedPubMedCentral Cardoso R, Guo F, Heisser T, et al. Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: a population-based study in 9 countries. Lancet Reg Health Eur. 2022;21:100458.CrossRefPubMedPubMedCentral
26.
go back to reference Borger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278–86.CrossRefPubMed Borger ME, Gosens MJ, Jeuken JW, et al. Signet ring cell differentiation in mucinous colorectal carcinoma. J Pathol. 2007;212:278–86.CrossRefPubMed
27.
go back to reference Brouwer NP, Webbink L, Haddad TS, et al. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer. J Pathol. 2023;261:401–12.CrossRefPubMed Brouwer NP, Webbink L, Haddad TS, et al. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer. J Pathol. 2023;261:401–12.CrossRefPubMed
28.
go back to reference Sun Y, Zhu D, Chen F, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016;35:4321–34.CrossRefPubMedPubMedCentral Sun Y, Zhu D, Chen F, et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene. 2016;35:4321–34.CrossRefPubMedPubMedCentral
29.
go back to reference Wang GH, Yao L, Xu HW, et al. Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett. 2013;5:544–8.CrossRefPubMed Wang GH, Yao L, Xu HW, et al. Identification of MXRA5 as a novel biomarker in colorectal cancer. Oncol Lett. 2013;5:544–8.CrossRefPubMed
Metadata
Title
Prognostic and predictive value of tumor deposits in advanced signet ring cell colorectal cancer: SEER database analysis and multicenter validation
Authors
Fuchao Li
Lei Liu
Qingzhao Feng
Xiaohong Wang
Fang Liu
Li Yang
Lin Miao
Weiming Wang
Guozhong Ji
Chenggong Yu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-024-03362-0

Other articles of this Issue 1/2024

World Journal of Surgical Oncology 1/2024 Go to the issue